betulinic acid has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Huang, E; Li, S; Liu, M; Liu, S; Shi, S; Song, G; Wang, J; Yuan, Z; Zhang, Y | 1 |
| Elyasi-Ebli, P; Gharaghani, S; Naderi Beni, R; Seyedarabi, A | 1 |
| Alhadrami, HA; Azhar, EI; Rateb, ME; Sayed, AM; Sharif, AM | 1 |
3 other study(ies) available for betulinic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Optimization, and biological evaluation of 3-O-β-chacotriosyl betulinic acid amide derivatives as novel small-molecule Omicron.
Topics: Amides; Amines; Anti-Retroviral Agents; Betulinic Acid; COVID-19; Humans; SARS-CoV-2 | 2023 |
In silico studies of anti-oxidative and hot temperament-based phytochemicals as natural inhibitors of SARS-CoV-2 Mpro.
Topics: Betulinic Acid; COVID-19; Curcumin; Humans; Lactams; Leucine; Molecular Docking Simulation; Molecular Dynamics Simulation; Nitriles; Phytochemicals; Polymers; Protease Inhibitors; SARS-CoV-2; Temperament | 2023 |
Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics.
Topics: Antiviral Agents; Betulinic Acid; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Olea; Pentacyclic Triterpenes; Protease Inhibitors; SARS-CoV-2; Triterpenes; Ursolic Acid | 2021 |